From the President of the International Atherosclerosis Society

Por Santos, Raul D.
Publicado no J Clin Lipidol (2020)

Estatinas e COVID-19: Suspender ou não Suspender? Eis a Questão!

Por Ferrari, Filipe, Santos, Raul D.
Publicado no Arq Bras Cardiol (2021)

PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia

Por Ito, Matthew K., Santos, Raul D.
Publicado no J Clin Pharmacol (2016)

Marked HDL deficiency and premature coronary heart disease

Por Schaefer, Ernst J., Santos, Raul D., Asztalos, Bela F.
Publicado no Curr Opin Lipidol (2010)

Association of Peripheral Arterial and Cardiovascular Diseases in Familial Hypercholesterolemia

Por Pereira, Carolina, Miname, Marcio, Makdisse, Marcia, Kalil, Roberto, Santos, Raul D.
Publicado em 2014

COVID-19 and Thromboinflammation: Is There a Role for Statins?

Por Ferrari, Filipe, Martins, Vítor M., Teixeira, Marcelo, Santos, Raul D., Stein, Ricardo
Publicado no Clinics (Sao Paulo) (2021)

Lipid Lowering Drugs: Present Status and Future Developments

Por Ruscica, Massimiliano, Ferri, Nicola, Santos, Raul D., Sirtori, Cesare R., Corsini, Alberto
Publicado no Curr Atheroscler Rep (2021)

The contribution of the systolic and diastolic components for the diagnosis of arterial hypertension under the 2017 ACC/AHA Guideline and metabolic heterogeneity among individuals...

Por Cesena, Fernando H. Y., Nary, Fernando C., Santos, Raul D., Bittencourt, Marcio S.
Publicado no J Clin Hypertens (Greenwich) (2020)

The challenge of multiple cardiovascular risk factor control outside Western Europe: Findings from the International ChoLesterol management Practice Study

Por Blom, Dirk J, Santos, Raul D, Daclin, Veronique, Mercier, Florence, Ruiz, Alvaro J, Danchin, Nicolas
Publicado no Eur J Prev Cardiol (2019)

Percepção Inadequada do Risco Cardiovascular e Baixo Conhecimento sobre Hipercolesterolemia Familiar em Indivíduos com Hipercolesterolemia Grave

Por Santos, Raul D., Pereira, Carolina, Cesena, Fernando, Laurinavicius, Antonio Gabriele, Tabone, Viviane, Bittencourt, Marcio Sommer
Publicado no Arq Bras Cardiol (2021)

Pre‐historic eating patterns in Latin America and protective effects of plant‐based diets on cardiovascular risk factors

Por Acosta Navarro, Julio C, Cárdenas Prado, Silvia M, Cárdenas, Pedro Acosta, Santos, Raul D, Caramelli, Bruno
Publicado em 2010

Hepatic Steatosis, Obesity and the Metabolic Syndrome Are Independently and Additively Associated With Increased Systemic Inflammation

Por Ndumele, Chiadi E., Nasir, Khurram, Conceiçao, Raquel D., Carvalho, Jose A. M., Blumenthal, Roger S., Santos, Raul D.
Publicado em 2011

Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: Results of 4 Phase III Trials

Por Santos, Raul D., Raal, MD Frederick J., Catapano, Alberico L., Witztum, Joseph L, Steinhagen-Thiessen, Elisabeth, Tsimikas, Sotirios
Publicado no Arterioscler Thromb Vasc Biol (2015)

Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension

Por Santos, Raul D., Duell, P. Barton, East, Cara, Guyton, John R., Moriarty, Patrick M., Chin, Wai, Mittleman, Robert S.
Publicado no Eur Heart J (2015)

Cardiovascular Risk Stratification and Statin Eligibility Based on the Brazilian vs. North American Guidelines on Blood Cholesterol Management

Por Cesena, Fernando Henpin Yue, Laurinavicius, Antonio Gabriele, Valente, Viviane A., Conceição, Raquel D., Santos, Raul D., Bittencourt, Marcio S.
Publicado no Arq Bras Cardiol (2017)

The Expected Cardiovascular Benefit of Plasma Cholesterol Lowering with or Without LDL-C Targets in Healthy Individuals at Higher Cardiovascular Risk

Por Cesena, Fernando Henpin Yue, Laurinavicius, Antonio Gabriele, Valente, Viviane A., Conceição, Raquel D., Santos, Raul D., Bittencourt, Marcio S.
Publicado no Arq Bras Cardiol (2017)

Low‐density lipoprotein‐cholesterol lowering in individuals at intermediate cardiovascular risk: Percent reduction or target level?

Por Cesena, Fernando H. Y., Laurinavicius, Antonio Gabriele, Valente, Viviane A., Conceição, Raquel D., Santos, Raul D., Bittencourt, Marcio S.
Publicado no Clin Cardiol (2018)

Clinical presentation, laboratory values, and coronary heart disease risk in marked high-density lipoprotein–deficiency states

Por Santos, Raul D., Asztalos, Bela F., Martinez, Lilton R. C., Miname, Marcio H., Polisecki, Eliana, Schaefer, Ernst J.
Publicado no J Clin Lipidol (2008)

Association of Omnivorous and Vegetarian Diets With Antioxidant Defense Mechanisms in Men

Por Cinegaglia, Naiara, Acosta‐Navarro, Julio, Rainho, Claudia, Antoniazzi, Luiza, Mattioli, Sarah, Pimentel, Caroline, Santos, Raul D., Sandrim, Valeria
Publicado no J Am Heart Assoc (2020)

Is Coronary Artery Calcification Associated with Vertebral Bone Density in Nondialyzed Chronic Kidney Disease Patients?

Por Filgueira, Agostinho, Carvalho, Aluizio Barbosa, Tomiyama, Cristiane, Higa, Andrea, Rochitte, Carlos E., Santos, Raul D., Canziani, Maria Eugênia F.
Publicado em 2011